Navigation Links
Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
Date:9/12/2007

SAN JOSE, Calif., Sept. 12 /PRNewswire-FirstCall/ -- Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) ("HPS" or "the Company") today announced the signing of an exclusive Agency Agreement with Brand Intelligence Group, Inc. ("BIG"), to reposition and promote the Company's Natural Attraction(R) brand, which contains its proprietary and patented human pheromone technology.

Under the terms of the Agreement, HPS and BIG will work together to develop a comprehensive program to repackage, reposition and promote the Natural Attraction brand, in order to capitalize on the potential strength of the trademark and its underlying technology.

In commenting on the Agreement, an HPS spokesperson indicated that the Company has been primarily focused on developing long-term relationships with leaders in the consumer products arena to incorporate the Company's mood-enhancing technology in products marketed and sold by such corporate partners. "While our primary focus has been successful in attracting industry leaders to incorporate our technology in their products, we have not focused our Natural Attraction line," said Bill Horgan, CEO, of the Company. In August of last year, the Company entered into a License Agreement with a Johnson & Johnson subsidiary, and most recently signed a non-exclusive agreement with Schwarkf and Henkel for several hair care lines. The Company noted that additional product introductions by Licensees are imminent.

BIG is a New York City-based consortium of branding, communication, licensing and marketing firms specializing in fragrance, fashion, lifestyle and luxury products. Co-presidents, Louis Iacovelli and Deborah Moses, are recognized experts in positioning and repositioning brands. Their collective client experience in beauty and fragrance include L'Oreal, Estee Lauder, Givenchy Fragrance, Coty Prestige, Dolce & Gabbana, Vera Wang, Gianni Versace, Yves Saint Laurent, Moschino, Joseph Abboud, Smash Box, Urban Decay, Ba
'/>"/>

SOURCE Human Pheromone Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Human Primary Preadipocytes and Differentiated Adipocytes
2. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
3. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
4. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
5. Human Universal cDNA Library Array I
6. Map and Link Human Genetic Disorders with SSLP Analysis
7. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
8. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
9. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
10. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
11. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , SEATTLE, Nov. 20 C...) announced today that the Ninth Circuit Court of ...uled that CTI should be allowed to pursue all of i... back to the District Court for trial. CTI filed ...hird-party reimbursement consultant for CTI,s prod...
(Date:11/19/2009)... COPENHAGEN, Nov. 19 Danish Prince...ellulosic ethanol plant in Kalundborg, Denmark, on...e world,s first and largest 2nd generation ethanol...se enzymes are used in the plant,s innovative proc...sion of Danisco, was the first to market with comm...
(Date:11/19/2009)..., NEW YORK, Nov. 19 NeoS... it has sent the following letter to its sharehold...ber 30, 2009, of China Biopharmaceuticals Holdings...mpany based in the People,s Republic of China. The...n Suzhou Eyre Pharmaceutical Co. Ltd., CHBP,s prim...
(Date:11/19/2009)..., MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeu...patient in a randomized Phase 2B study of AEG35156...velopment for multiple oncology indications. ,,...se 2 Study of the X-Linked Inhibitor of Apoptosis ...h High-dose Cytarabine and Idarubicin in AML Follo...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
... May 7 Cadence Pharmaceuticals, Inc. (Nasdaq: C...icensing, developing and commercializing proprieta...ospital setting, today reported financial results ...We have now completed the clinical development pro...on of intravenous acetaminophen for the treatment ...
...Calif., May 7 AutoImmune Inc. (OTC Bulletin Board...$0.01 per share basic and diluted, for the three m...ss of $107,000, or $0.01 per share basic and dilut... of March 31, 2009, the Company reported $8.5 mill...ount reported as of December 31, 2008. , , Chair...
...eeded to train workforce, stimulate economy , , ...eiled its Fiscal Year 2010 budget request, proposi...d Technical Education Act (Perkins Act) at $1.3 bi...deral funding that supports local education progra...The Association for Career and Technical Education...
Other Biology Technology:Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 2Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 3Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 4Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 5Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 6Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 7AutoImmune Inc. Reports 2009 First Quarter Financial Results 2AutoImmune Inc. Reports 2009 First Quarter Financial Results 3AutoImmune Inc. Reports 2009 First Quarter Financial Results 4Obama Budget Level Funds Career Technical Education 2Obama Budget Level Funds Career Technical Education 3
(Date:11/19/2009)...ate fungus for food, have many remarkable qualitie...nt farmers, like their human counterparts, depend ...grow. The finding, reported this week (Nov. 20) in...nown symbiosis between ants and bacteria and provi... dominate the American tropics and subtropics. , ...
(Date:11/19/2009)... multi-institutional effort co-led by three Cold S...ed today in publication of a landmark series of pa...dented detail the DNA sequence of maize ( Zea mays...rth American consumers, is one of the world,s most...al crop grown in the United States, representing $...
(Date:11/19/2009)...ainable farming, initially adopted to preserve soi...role in maintaining a healthy climate, according t...dge and Los Alamos national laboratories. , ORNL...tial of the earth,s soils to sequester carbon, wit...ould greatly reduce U.S. carbon emissions by as mu...
Breaking Biology News(10 mins):Like humans, ants use bacteria to make their gardens grow 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3Sex Hormone Protein May Predict Type 2 Diabetes 53775 1Sex Hormone Protein May Predict Type 2 Diabetes 53775 2Sex Hormone Protein May Predict Type 2 Diabetes 53775 3PDI Reports 2009 Second Quarter Financial Results 13399 1PDI Reports 2009 Second Quarter Financial Results 13399 2PDI Reports 2009 Second Quarter Financial Results 13399 3PDI Reports 2009 Second Quarter Financial Results 13399 4PDI Reports 2009 Second Quarter Financial Results 13399 5PDI Reports 2009 Second Quarter Financial Results 13399 6PDI Reports 2009 Second Quarter Financial Results 13399 7PDI Reports 2009 Second Quarter Financial Results 13399 8PDI Reports 2009 Second Quarter Financial Results 13399 9Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 1Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 2Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 3Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 4Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 5Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 6Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 7
... regulatory gene that shows clear evidence of evol... evolution of humans might well have depended in p...rphin (PDYN), that plays critical roles in regulat...ed that, compared to lower primates, humans posses... the prodynorphin gene, which is a precursor molec...
...rnal of Experimental Medicine identifies a small g...g active tuberculosis (TB). Pedro Flores-Villanue...ealth Center (Tyler, TX) studied groups of patient...ho carry this genetic change were more likely to d...ria. , Infections with Mycobacterium tuberculosis,...
...t forms—beetles, flies, dragonflies, mosquitoes, g...rs—evolved? , Insects make up 75% of all species k...ly a result of a combination of one or more factor...ciation, an ability to adapt to new environments a... of extinction. Speciation, adaptation, and extinc...
Other Biology News:Key brain regulatory gene shows evolution in humans 2Key brain regulatory gene shows evolution in humans 3Key brain regulatory gene shows evolution in humans 4Gene increases risk of tuberculosis 2Adult stem cells aid recovery in animal model of cerebral palsy 2
Anti-Neurotensin Receptor Monoclonal Antibody, Unconjugated , Clone B-N6 from Cell Sciences
Goat Anti-Human HNF4 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Human SART1 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-IkappaB-alpha Monoclonal Antibody, Unconjugated, Clone 112B2 from Cell Signaling Technology
Biology Products: